Arabic Arabic English English French French German German
dark

Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer

– Dr. Ruffner is a US-trained hematologist/oncologist with over 25 years of clinical care, oncology biotechnology and pharmaceutical drug development experience
– Mr. Levine has over 20 years of corporate and investment banking experience in the biotechnology and pharmaceutical sectors
– Inducement Grants Issued Pursuant to Nasdaq Listing Rule 5635(c)(4) Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

Next Post

Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning

Related Posts
Total
0
Share